22.418 articles found

Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer.

Kietpeerakool C, Tiyayon J, Suprasert P, Kanjanavanit R, Srisomboon J.

J Med Assoc Thai · 2006-11-01

PMID: 17205858

[Parkinson disease: clinical considerations and treatments].

de Beyl ZD, Thibaut P.

Rev Med Brux · 2006-11-01

PMID: 17256421

Ziprasidone therapy in elderly patients with psychotic mood disorders and Parkinson's disease.

Berkowitz AL.

Psychiatry (Edgmont) · 2006-11-01

PMID: 20877519

SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES.

SNOW ALAN D, NGUYEN BETH P, LAKE TOMAS P, CASTILLO GERARDO M, WEIGELE MANFRED.

· 2006-10-31

USE OF ANDROGENS FOR THE TREATMENT OF PARKINSON' S DISEASE

XU Jin, ZHONG Nan.

· 2006-10-20

Use of Androgens for the Treatment of Parkinson's Disease

XU JIN, ZHONG NAN.

· 2006-10-20

Use of potassium voltage channel 1.5 inhibitors for producing a medicament for the therapy or prophylaxis of e.g. respiratory disorders, upper airway resistance syndrome, neurodegenerative disorders and lung cancer

Check source for author details

· 2006-10-20

Effectiveness of physiotherapy in Parkinson's disease: the feasibility of a randomised controlled trial.

Keus SH, Bloem BR, van Hilten JJ, Ashburn A, Munneke M.

Parkinsonism Relat Disord · 2006-10-20

DOI: 10.1016/j.parkreldis.2006.07.007PMID: 17055767

Clinical relevance of rehabilitation programs for Parkinson's disease. I: Non-symptom-specific therapeutic approaches.

Jöbges M, Spittler-Schneiders H, Renner CI, Hummelsheim H.

Parkinsonism Relat Disord · 2006-10-20

DOI: 10.1016/j.parkreldis.2006.07.019PMID: 17055765

Clinical relevance of rehabilitation programs for patients with idiopathic Parkinson syndrome. II: Symptom-specific therapeutic approaches.

Jöbges EM, Spittler-Schneiders H, Renner CI, Hummelsheim H.

Parkinsonism Relat Disord · 2006-10-20

DOI: 10.1016/j.parkreldis.2006.07.018PMID: 17055766

PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF PARKINSON'S DISEASE CONTAINING 1,2-DI[2-METHOXY-4-(2-CARBOXYLVINYL)]PHENOXYETHANE AS AN ACTIVE INGREDIENT

SHIN KYE JUNG, KIM DONG JIN, HWANG ON YOU.

· 2006-10-19

Methods for therapy of neurodegenerative disease of the brain

TUSZYNSKI MARK H.

· 2006-10-17